Published
Mobilee Hyaluronic Acid Clinical Trial Results for Joints: What the Studies Actually Show
Mobilee® keeps turning up on supplement labels, parked beside words like mobility and cushioning. What do the Mobilee hyaluronic acid clinical trial results for joints actually say? The short answer is promising, but small, with real caveats.
You'll get the numbers, the wins, and the gaps. The main Mobilee hyaluronic acid studies run from a 40-person pilot to an 80-person trial. Men responded more clearly than women, and every trial used dairy, not capsules.
A supplement like Joint Genesis packs 80 mg of Mobilee® into each capsule, which is why this research matters to your buying decision. Check the numbers, then judge the evidence yourself.
What Is Mobilee and How Does Its Hyaluronic Acid Work?
Mobilee®
Rooster combs supply the raw material for Mobilee®, a patented extract packed with hyaluronic acid, polysaccharides, and collagen. Behind the extract sits Bioiberica, a Spanish biotech company that built it for joint health. One gene-expression study listed the hyaluronic acid content at 65%, which makes it the dominant ingredient in the extract.
Picture hyaluronic acid as a gel-like molecule sitting in the fluid that cushions your joints. Once osteoarthritis sets in, the molecule breaks into smaller pieces and loses viscosity and elasticity. Then cartilage takes more of the strain.
Injections put hyaluronic acid straight into the knee. By contrast, Mobilee takes the swallowed route. You take it daily, and the idea is that its hyaluronic acid, polysaccharides, and collagen support your joint's own cushioning over time.
In 2021, a study of 55 dogs after cruciate ligament surgery linked oral Mobilee to higher joint hyaluronic acid production. Animal data, though. Dogs can't rate their pain from 0 to 10, so read it as a clue, not proof.
Back in October 2013, Bioiberica launched the ingredient. You'll now find it in a Spanish athletes' milk drink and, since 2020, in a Nestlé Health Science mobility blend.
Quick Answer: What Do the Mobilee Clinical Trials Show?
Adults with mild knee discomfort who took Mobilee® daily for about 12 weeks gained more knee muscle strength than placebo groups in small, placebo-controlled trials. Across 148 volunteers, a pooled analysis added less joint fluid swelling and lower pain scores, mainly in men over 50. Three catches temper that. Every trial used dairy, the maker helped run them, and women didn't match the men's gains in the 2015 trial.
Early, but consistent. On knee strength, several small trials point the same way. Pain and daily-function results stay mixed.
Mobilee Clinical Trials at a Glance
Four studies, one table. Compare the size, format, and results of the main human studies side by side.
| Study | Participants | Format and Dose | Length | Main Finding |
|---|---|---|---|---|
| Martinez-Puig et al., 2013 | 40 adults with joint discomfort (20 per group) | Daily yogurt with Mobilee or plain yogurt | 90 days | Higher knee strength than placebo at 240°/s (p<0.05); no clear change in Lequesne score |
| Sánchez et al., 2014 | 20-person blood subset (10 per group) | Daily Mobilee yogurt or control yogurt | 90 days | About 157 genes differed from placebo; lower pain and joint fluid reported |
| Solà et al., 2015 | 80 adults with mild knee pain (40 per group) | 125 mL low-fat yogurt with 80 mg Mobilee, or plain | 12 weeks | Strength measures up at least 11% in men; no difference in women |
| Pooled analysis, 2015 (Vitafoods) | 148 volunteers across two trials | 80 mg daily in a low-fat dairy product | 3 months | Better knee flexion work, less joint fluid, lower pain scores, mainly in men over 50 |
Placebo groups appear in every study above. And every one tested Mobilee inside a dairy product, not a capsule.
Don't take the table on faith. ClinicalTrials.gov lists an 80-person, quadruple-blind Mobilee yogurt trial under NCT01303432, sponsored by Bioiberica, so paste that number in and read the sponsor line.
The 2013 and 2015 Trials, Result by Result
Numbers beat adjectives. Here's what each trial measured and found.
Strength got tested on an isokinetic dynamometer, a machine that records how hard your legs push. Peak torque marks your single hardest push, total work adds up the whole set, and mean power shows how quickly you deliver it. Those 180°/s and 240°/s labels just name the two test speeds.
2013 Pilot: 40 Adults, 90 Days
- Design: a randomized, double-blind, placebo-controlled setup with 20 adults per group.
- What they ate: one yogurt a day for 90 days, either with the hyaluronic acid product or without it.
- At 240°/s: knee extensor peak torque (twisting force) rose 6.5 Nm on Mobilee and fell 1.0 Nm on placebo (p<0.05).
- Next, at 180°/s: the comparison read 7.6 Nm versus 2.5 Nm, which just missed statistical significance (p=0.0582).
- Everyday function: total work and mean power followed suit, but the Lequesne and SF-36 questionnaires showed no clear difference.
2015 Trial: 80 Adults, 12 Weeks
- Design: a randomized, double-blind, placebo-controlled trial with 40 adults per group and an average age near 43.
- Who joined: adults with mild knee pain lasting at least six months, which the authors linked to early osteoarthritis.
- Daily dose: 125 mL of low-fat yogurt, holding either 80 mg of Mobilee or none at all.
- Men: affected knees gained at least 11% over control at 180°/s in peak torque, total work, and mean power (p<0.05).
- For women: 50 of the 80 volunteers were women, and none of their strength measures differed from control.
- Authors' read: long-term Mobilee yogurt is a dietary tool for men's muscle strength, and the sex gap needs more research.
Look at what both trials measured. Muscle strength around the knee, not cartilage thickness or X-rays. That makes the result a useful signal, but not proof of rebuilt joints.
Pooled Results and Gene Findings: What They Add
Two follow-up analyses widen the picture, one pooling trial data and the other examining participants' blood. Different tools, different angles.
The pooled analysis combined two earlier double-blind trials. Participants aged 20 to 75 took 80 mg of Mobilee or a placebo daily in low-fat dairy for three months. A Biodex dynamometer tracked strength, ultrasound tracked joint fluid, and a visual scale tracked pain.
| Outcome | How Researchers Measured It | What They Reported | Weight of Evidence |
|---|---|---|---|
| Knee muscle strength | Isokinetic dynamometer (peak torque, total work, mean power) | Higher than placebo in the 2013 and 2015 trials, clearer in men | Repeated across trials |
| Pain | Visual Analogue Scale | Lower perceived pain in the pooled 148-person analysis, mainly in men over 50 | Promising, not uniform |
| Joint fluid (synovial effusion) | Ultrasound | Smaller effusion in the pooled analysis and the gene study | Early signal |
| Daily function | Lequesne index and SF-36 survey | No clear difference in the 2013 trial | No benefit shown |
| Gene activity | Blood microarray in 20 participants | About 157 genes differed, including lower MMP23B activity, a gene tied to tissue breakdown | Lab clue only |
Gene data can't tell you how your knees will feel, and a 20-person sample is far too small to settle anything. It only tells researchers where to look next.
Mobilee vs Other Hyaluronic Acid Options
Three routes carry hyaluronic acid toward your joints. The evidence behind each one looks different.
| Feature | Mobilee Trials | Other Oral Products | Injections |
|---|---|---|---|
| How you get it | Daily dose in a dairy product | Daily oral preparations | A clinician injects it into the knee |
| Who took part | Adults with mild knee discomfort or pain | Adults with mild to moderate knee osteoarthritis | Adults with knee osteoarthritis |
| Study length | About 3 months | 1 to 4 months | Up to 26 weeks |
| What researchers reported | Better knee strength, plus lower pain scores in pooled data | Better pain and function scores in most of 15 reviewed reports | Small gains versus oral NSAIDs, statistically significant but not clinically important |
Promising, said the oral hyaluronic acid review of the clinical data, but the trials were small. Mobilee's research earns the same asterisk.
Statistically significant means a result probably isn't luck. A clinically important difference is one you'd feel in daily life, like easier stairs or a shorter stretch of morning stiffness. Hold every study to both standards.
Strengths and Limits of the Mobilee Research
What Holds Up
- The main trials used placebo-controlled, double-blind designs.
- Objective measures backed the results, from dynamometer strength tests to ultrasound scans of joint fluid.
- Strength gains showed up in more than one separate trial.
- At 80 mg a day, the 2015 trial used a modest dose.
- The EU gave Mobilee Novel Food authorization, and it holds GRAS status in the United States.
What Needs Caution
- Sample sizes stayed small, at 40 to 80 adults per trial.
- The company that makes Mobilee, Bioiberica, helped run or write the key studies.
- Dairy, not capsules, carried the dose in every trial.
- No strength gain appeared in women on any measure in the 2015 trial.
- Follow-up ended at three months.
- Treat the pooled analysis as a company-reported result, since Bioiberica announced it at an industry trade show.
Limits like these don't sink the research. They shrink the promises you should read into it.
Stronger proof needs larger trials, independent funding, capsule-format testing, balanced numbers of men and women, and follow-up well beyond three months. Until those studies arrive, treat today's results as an encouraging first chapter. Not the final word.
How the Trial Dose Compares With Joint Genesis
The 2015 trial used 80 mg of Mobilee® a day, the same amount packed into every Joint Genesis capsule. Past that number, the setups split, with yogurt in the trial and a capsule here.
| Detail | Mobilee Trials | Joint Genesis |
|---|---|---|
| Daily Mobilee dose | 80 mg (2015 trial) | 80 mg in one capsule |
| Format | 125 mL low-fat yogurt | Capsule taken with water |
| Other active ingredients | None added to the test yogurt | French maritime pine bark, Ginger Root, Boswellia Serrata, BioPerine® |
| Length of use | About 3 months | About 3 months for results to build |
| Human trial on this exact product | Yes, on the Mobilee yogurt | None cited on the homepage |
Joint Genesis names Mobilee® its lead ingredient, a patented extract that supports your body's own hyaluronan. French maritime pine bark adds antioxidant support. Ginger Root and Boswellia Serrata add traditional comfort support, while BioPerine® supports absorption.
So the research backs Mobilee as an ingredient. Ingredient, not formula. It doesn't prove what the full formula does for you, because pine bark, ginger, Boswellia, and BioPerine® never shared a trial with Mobilee in these studies.
Safety and Who Should Ask a Doctor First
- Regulators have weighed in. The European Food Safety Authority gave rooster comb extract in dairy products a favorable opinion. Mobilee also holds EU Novel Food authorization and GRAS status in the United States.
- The maker ran its own stability and toxicity studies, and the results it reports call the product safe and stable.
- Because Mobilee comes from an animal source, tell your doctor about any food allergies.
- Talk to your doctor first if you're pregnant, nursing, taking prescription medication, or managing a health condition.
- The studies covered about three months of daily use, so ask your doctor before you plan anything longer, since no trial here tracked beyond that.
- If new or worsening symptoms show up after you start, call your doctor.
- Lingering or worsening joint pain needs a proper diagnosis. Not a supplement.
How to Give Mobilee a Fair 12-Week Test
Studies can only take you so far. Your own knees get the final vote, so run the test the way researchers would.
Step 1: Check With Your Doctor
Before you start anything new, share your medications, allergies, and joint history.
Your doctor can confirm whether a Mobilee-based formula fits your plan, or point you toward a better route.
Step 2: Record Your Baseline
Jot down how long morning stiffness lasts and how far you can walk comfortably.
A pain rating from 0 to 10 goes in too, a simple cousin of the scale researchers use.
Step 3: Take It Daily for 12 Weeks
Three months is how long the trials ran, so hold your verdict until then.
For the Joint Genesis supplement, the routine is one capsule with water every day. A capsule needs no measuring, unlike the 125 mL trial yogurt.
Step 4: Track One Day Each Week
Choose one day and time each week, then rate your pain, stiffness, and stair comfort on the same 0 to 10 scale.
Memory blurs. Weekly snapshots don't.
Step 5: Keep Your Muscles Working
Knee strength was the trials' yardstick. Don't neglect yours.
Your doctor can say which movement suits you, and you can add it alongside your capsule.
Step 6: Review Honestly
Set your week-12 notes next to your baseline, and pair the capsule with good sleep and healthy habits.
Nothing moved? Then you have your answer, and the 180-day guarantee on Joint Genesis gives you room to act on it.
Quick Tips: How to Judge Any Joint Supplement Trial
- A placebo group and double-blind labeling belong at the top of your checklist.
- Sample size matters, so treat studies under 100 people as early signals.
- Always find the funder and the authors' affiliations.
- The study's dose and format should match the product in your hand.
- Confirm who improved, men or women or both.
- Finally, search the study title on PubMed or ClinicalTrials.gov, then read the original.
Guessing for twelve weeks gets you nowhere. Written notes give you something concrete to show your doctor.
Final Thoughts on Mobilee Hyaluronic Acid Trial Results
Modest, but real. That's why the Mobilee clinical trials deserve a look. Daily doses beat placebo on knee strength, and pooled data showed less joint fluid and lower pain scores.
Still, the studies stayed small and short, and the maker helped run them. Men responded more clearly than women, and every trial used dairy. On the finished capsule, the homepage cites no trial at all.
These Mobilee hyaluronic acid clinical trial results for joints point to a promising ingredient, not a guaranteed fix. If you want to try it, order from the official Joint Genesis website, talk to your doctor first, and give it a full 12 weeks.
Mobilee Hyaluronic Acid Clinical Trial FAQs
What is Mobilee hyaluronic acid?
Bioiberica, a Spanish biotech company, developed Mobilee®, a patented extract of rooster combs. Hyaluronic acid leads the mix, with polysaccharides and collagen alongside it. Researchers tested it in dairy products for knee comfort, muscle strength, and mobility at a daily dose of 80 mg.
How many clinical trials support Mobilee?
Bioiberica cites six preclinical studies and five randomized clinical trials. The main human work covered here includes a 40-person trial, an 80-person trial, a pooled analysis of 148 volunteers, and a gene-expression study. Small samples mean you should read the totals as encouraging, not conclusive, and look for independent replication.
What dose of Mobilee did the trials use?
Both the 2015 trial and the pooled analysis used 80 mg a day, mixed into a low-fat dairy product. Industry material puts Mobilee's low dose range at 40 to 80 mg. At 80 mg per capsule, Joint Genesis matches the dose used in those studies.
How long did participants take Mobilee in the studies?
Participants took it daily for about three months, either 90 days or 12 weeks. No trial covered here tracked results past that window, so years of use remain untested. What the evidence backs is a fair 12-week test, not a verdict after a week or two.
Does Mobilee work differently for men and women?
In the 2015 trial, men's knee strength rose at least 11% against control. The 50 women among the 80 participants showed no difference on any strength measure. Men over 50 also stood out in the pooled analysis, and only more studies can explain why the sexes differ.
Is Mobilee the same as hyaluronic acid injections?
No, they're different things. A clinician injects hyaluronic acid directly into the knee. Mobilee comes as a daily oral extract, with hyaluronic acid sitting alongside other compounds. Evidence differs too, because injection studies focus on people with osteoarthritis while Mobilee studies enrolled adults with mild discomfort.
Is Mobilee safe to take?
The European Food Safety Authority gave rooster comb extract in dairy products a favorable opinion. GRAS status in the United States and EU Novel Food authorization back that up. Even so, ask your doctor first if you're pregnant, nursing, taking medication, or managing a health condition. A regulator's opinion doesn't replace personal medical advice.
Has Joint Genesis been tested in a clinical trial?
The Joint Genesis homepage cites no clinical trial on the finished capsule. This guide's research tests Mobilee, the lead ingredient, which Joint Genesis supplies at 80 mg per capsule. Individual results vary, since the other four ingredients never shared a trial with Mobilee here.
Did the Mobilee trials include people with osteoarthritis?
Not exactly. Participants had mild knee pain or joint discomfort, which the 2015 authors described as a symptom of early osteoarthritis. These results say little about advanced joint damage, so don't read them as proof for severe or long-standing osteoarthritis.
Who ran the Mobilee clinical trials?
Bioiberica, the company behind Mobilee, ran or co-authored the key studies. Spanish partners joined in, including Universitat Rovira i Virgili and the Poal Institute of Rheumatology. Company involvement doesn't erase the results, but it does call for caution. Independent replication, ideally in a capsule format, would make the Mobilee hyaluronic acid clinical trial results for joints more convincing.